medRxivGenetic & Genomic MedicinePreprint
The qMini assay identifies an overlooked class of splice variants
Bin GuaniD, Chelsea Bender, Madhulatha PantrangiiD, Nia Moore, Melissa J. ReevesiD, Amelia NaikiD, Huirong LiiD, Kerry GoetziD, Delphine BlainiD, Aime R. Agather, Catherine A. CukrasiD, Wadih M. ZeiniD, Laryssa A. HuryniD, Brian P. BrooksiD, Robert B. HufnageliD
Abstract
Splice variants are known to cause diseases by utilizing alternative splice sites, potentially resulting in protein truncation or mRNA degradation by nonsense-mediated decay. Splice variants are verified when altered mature mRNA sequences are identified in RNA analyses or minigene assays. Using a quantitative minigene assay, qMini, we uncovered a previously overlooked class of disease-associated splice variants that did not alter mRNA sequence but decreased mature mRNA level, suggesting a potentially new pathogenic mechanism.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protocol for designing and interpreting minigene assays to validate candidate splice altering variants
Whitney Whitford, Suzanne M. Musgrave, … Jessie C. Jacobsen·bioRxiv·May 8, 2026
- Determining the pathogenicity of MUT gene variant by mini-gene splicing assay
Yanyun Wang, Yun Sun, Tao Jiang·bioRxiv·Feb 19, 2021
- Protocol for a minigene splice assay using the pET01 vector
Hannah Andreae, Marialessandra Curcio, … Barbara Vona·STAR ProtocolsPeer-reviewed·Jun 18, 2025
- Transcriptome-wide outlier approach identifies individuals with minor spliceopathies
Taylor M. Maurer, Rodrigo Mendez, … Vijay S Ganesh·The American Journal of Human GeneticsPeer-reviewed·Sep 19, 2025
- Functional Assays Reclassify Suspected Splice-Altering Variants of Uncertain Significance in Mendelian Channelopathies
Matthew J. O’Neill, Yuko Wada, … Dan M. Roden·Circulation Genomic and Precision MedicinePeer-reviewed·Oct 5, 2022
- A novel splice site variant in DEGS1 leads to aberrant splicing and loss of DEGS1 enzyme activity, a VUS resolved
Holly C. Beale, Victor Tse, … Anne Michele Slavotinek·Human GeneticsPeer-reviewed·May 6, 2026